Medical Devices & Supplies - Diversified Stocks Q2 Teardown: Stryker (NYSE:SYK) Vs The Rest
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Stryker (NYSE:SYK) and the best and worst performers in the medical devices & supplies - diversified industry.
YahooyesterdaySYK
ISRG Stock: The Best House On The Block Costs The Most
In the world of robotic surgery, one company is both the undisputed leader and the most expensive option, forcing investors to ask if operational excellence is worth the premium.
YahooyesterdaySYK
The Wide Divide Priced Into Boston Scientific Stock
The market's valuation reflects a wide breadth of potential outcomes for the company, exposing shareholders to the full magnitude of that underlying risk.
YahooyesterdaySYK
Enovis inks eCential takeover to develop surgical ortho robots
The orthopedics specialist aims to launch a knee robot in late 2028, followed by a shoulder robot in 2029.
Yahoo2 days agoSYK
Stryker (SYK) Wins FDA Nod And Completes First Procedure With New Surgery Software
Stryker (NYSE:SYK) received FDA De Novo authorization for its SportSuite Vision software on Apple Vision Pro in a clinical setting. The company reported completion of the first surgical procedure using SportSuite Vision in an operating room environment. The software introduces augmented reality and spatial computing tools into surgical workflows and operating room visualization. The authorization marks a regulatory milestone for Stryker in mixed reality applications for healthcare. This...
Yahoo2 days agoSYK
Stryker to add rotator cuff repair tech with ZuriMED buy
Rotator cuff augmentation is one of the fastest-growing areas in sports medicine, according to Stryker.
Yahoo2 days agoSYK
Stryker to Acquire ZuriMED to Expand Its Shoulder Care Portfolio
SYK's planned ZuriMED acquisition adds the FiberLocker System, aiming to strengthen its shoulder portfolio and rotator cuff care capabilities.
Yahoo3 days agoSYK
Intuitive Surgical Stock Has Fallen While Its Operating Margin Keeps Widening
With US procedure growth slowing and the shares well below their high, the operating margin has widened in each of the last three years.
Yahoo13 days agoSYK
US$100 Million Defense Contract Win Might Change The Case For Investing In Stryker (SYK)
Stryker’s sales unit in Michigan previously secured a US$100.00 million contract modification from the U.S. Defense Logistics Agency, underscoring its role as a key supplier to government healthcare and logistics systems. This award highlights the importance of stable government contracting as a complement to Stryker’s hospital and surgical product revenue mix. We’ll now examine how this sizable Defense Logistics Agency contract influences Stryker’s investment narrative, particularly its...
Yahoo14 days agoSYK
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.
Yahoo14 days agoSYK
Stryker (SYK) Wins $100 Million Contract, Is It Still Below Fair Value?
Stryker (SYK) is back in focus after its Stryker Sales unit secured a $100 million contract modification from the US Defense Logistics Agency, a development that coincided with a 2.7% share price move. See our latest analysis for Stryker. For context, Stryker’s share price has been volatile around recent news, with a 4.17% 1 month share price return and a 5.88% decline year to date, while the 1 year total shareholder return is down 13.98%, the 3 year total shareholder return is up 23.40%, and...
Yahoo14 days agoSYK
Stryker Board Member Sold $117.78M In Company Stock
Ronda E Stryker, Board Member at Stryker (NYSE:SYK), reported an insider sell on August 20, according to a new SEC filing. What Happened: After conducting a thorough analysis, Stryker sold 350,000 shares of Stryker.
Benzinga14 days agoSYK
Should Investors Buy STERIS as Growth Meets Reasonable Valuation?
STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.
Yahoo15 days agoSYK
Enovis: Executing Better, But Still Remains Stuck In A Med-Tech No Man's Land
Enovis is gaining share in joint reconstruction, leveraging new products and capitalizing on competitor disruptions. Learn more about ENOV stock here.
SeekingAlpha15 days agoSYK
Disappointing Ortho Performance Continues To Hold Smith & Nephew Back (Downgrade)
Smith & Nephew stock is downgraded to 'Hold' amid weak orthopedics, a guidance cut, and exec turnover. Here's what you need to know about SNN.
SeekingAlpha16 days agoSYK
A Congress Member Bought Up To $60K In Amazon.com Stock: Here's What You Need To Know
Records from August 18, 2026 indicate that Representative Thomas Kean of New Jersey made a purchase of Amazon.com (NASDAQ:AMZN), valued between $4,004 and $60,000, with the transaction dated July 8, 2026 and filed in
Benzinga16 days agoSYK
Stryker Corporation: Hold For Quality, Wait For The Dip
Stryker is a MedTech compounder with 11% organic revenue growth and expanding margins. Click here to read why SYK stock is a Hold.
SeekingAlpha17 days agoSYK
Stryker (NYSE:SYK): A Quality Investment for Long-Term Investors
Stryker (SYK) passes the Caviar Cruise quality screen: strong growth, 36% ROIC, and solid cash conversion. A quality investing standout.
ChartMill21 days agoSYK
Wolfe Research Downgrades Stryker (SYK)
Fintel21 days agoSYK
Can Stryker (SYK) Still Look Undervalued After Backlog Recovery?
Stryker stock has delivered a 35.9% gain over the past five years, yet current checks suggest it is not an obvious bargain, even as an Intrinsic Value estimate using a Discounted Cash Flow (DCF) framework points to the shares trading below that intrinsic value by 19.8%. Stryker's 35.9% return over five years indicates the stock has rewarded long term holders. New investors now need to weigh valuation more carefully than during earlier stages of the move. Strong demand for Stryker's medical...
Yahoo21 days agoSYK